Background The minimally important difference (MID) for frailty variation associated with adverse outcomes remains unknown in ...
Background We aimed to estimate mental disorder disparities in cardiovascular disease (CVD) incidence and determine whether ...
Background Many observational studies highlight clonal haematopoiesis (CH) as a novel determinant of cardiovascular disease ...
Objective To clarify whether atherogenic index of plasma (AIP), a comprehensive indicator reflecting both the protective and ...
Background Atrial fibrillation (AF)-induced cardiomyopathy (AIC) is characterised by reversible left ventricular (LV) dysfunction after restoration of sinus rhythm (SR). The need for continued ...
Objective To test the effectiveness of an impedance cardiography (ICG) guided treatment strategy on improving blood pressure (BP) control in real-world clinical practice. Design A single-centre, ...
Background Revised haemodynamic criteria for pulmonary hypertension (PH)—mean pulmonary artery pressure (mPAP) >20 mm Hg and pulmonary vascular resistance (PVR) >2 Wood Units (WU)—have defined new ...
Background Transcatheter aortic valve replacement (TAVR) has emerged as an alternative treatment for aortic regurgitation (AR) in patients at high surgical risk. However, evidence comparing outcomes ...
Objective Sudden cardiac arrest (SCA) is the most devastating outcome in hypertrophic cardiomyopathy (HCM). We evaluated repolarisation features on the surface electrocardiogram (ECG) to identify the ...
Background Disturbances of copper (Cu) homeostasis can lead to hypertrophic cardiac phenotypes (eg, Wilson’s disease). We previously identified abnormal Cu homeostasis in patients with hypertrophic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback